JPRN-C000000009已完成未知
Treatment for steroid-resistant nephrotic syndrome in children: a combination of cyclosporine and prednisolone in minimal change and a combination of methylprednisolone, cyclosporine and prednisolone in FSGS - Treatment for steroid-resistant nephrotic syndrome in children: a combination of cyclosporine and prednisolone in minimal change and a combination of methylprednisolone, cyclosporine and prednisolone in FSGS
Japanese Study Group of Renal Disease in Children0 个研究点目标入组 60 人开始时间: 2005年8月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 1years-old 至 18years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Congenital nephrotic syndrome. 2.Other renal or systemic forms of nephrotic syndrome defined on renal biopsy, clinical features or serology (Henoch-Schönlein nephritis, systemic lupus erythematosus). 3.Medical history of allergy or hypersensitivity reactions to methylprednisolone and cyclosporine. 4.Poorly controlled hypertension. 5.Chronic renal dysfunction. 6.Active infectious disease. 7.Severe liver disfunction. 8.History of cyclosporine administration. 9.Pregnancy. 10.Judged inappropriate for this study by the physicians.
研究者
相似试验
已完成
不适用
Optimal treatment of steroid sensitive nephrotic syndrome in childreMinimal Change Nephrotic Syndrome(MCNS), Nephrotic syndromeUrological and Genital DiseasesNephrotic syndromeISRCTN27871415Erasmus Medical Centre (Netherlands)340
进行中（未招募）
1 期
Treatment of steroid-resistant chronic graft-versus-host-disease with regulatory T cellsTreatment of steroid-resistant chronic graft-versus-host disease with donor-derived regulatory T cellsMedDRA version: 20.0 Level: SOC Classification code 10021428 Term: Immune system disorders System Organ Class: 10021428 - Immune system disordersEUCTR2016-003947-12-DEFreistaat Bayern represented by University of Regensburg represented by Kaufmännischer Direktor27
进行中（未招募）
不适用
Treatment of steroid resistant grade II to IV acute GVHD by infusion of mesenchymal stem cells expanded with human plasma and platelet lysate ; a phase I/II study - MSC for resistant GVHDEUCTR2007-003341-32-NLniversity medical Center Utrecht10
已完成
3 期
Initial treatment of idiopathic nephrotic syndrome in children with mycophenolate mofetil vs. prednisone: A randomized, controlled, multicenter studyN04.9DRKS00006547niversitätsklinikum Heidelberg272
进行中（未招募）
1 期
Initial treatment of nephrotic syndrome in childreEUCTR2014-001991-76-DERuprecht-Karls-University Heidelberg, Medical Faculty represented by Universitätsklinikum Heidelberg and its Commercial340